News
Aetion and Cegedim expand real-world data partnership
Aetion and Cegedim Health Data have extended their partnership for another three years, ...
News
Data firms form Real-World Evidence Alliance, giving them a voice with US FDA, Congress
Established by five real-world data and analytics companies, the new group provides a ...
News
Health tech companies form a new coalition to advance the role of real-world data
Five health data analytics companies announced they have banded together to form an ...
News
Aetion hauls in $110M Series C to fuel global growth in real-world evidence space
Fierce Healthcare reports that Aetion, which offers real-world evidence and analytics to ...
News
Aetion doubles lifetime funding with $110M series C for real-world data platform
Fierce Biotech reports in 2021 that Aetion, a real-world evidence platform, has secured ...
News
Real-world evidence startup Aetion lands $110M in Series C as it looks toward global expansion
Aetion, a tech startup focused on real-world evidence in healthcare, landed $110 million ...
News
RWE upstart maps a new global plan as investors pour in the latest mega-round
As regulators continue to rely more on real world evidence, New York-based RWE leader ...
News
ICER pilot project to use real-world evidence in hereditary angioedema treatments value assessment update
Evidence Base Online reports The Institute for Clinical and Economic Review (ICER; MA, ...
News
ICER to incorporate RWE into assessment of HAE drugs
The US Institute for Clinical and Economic Review (ICER) has announced that it is using ...
News
ICER launches pilot program to update past assessments using real-world data
Jazz Pharmaceuticals has received priority review from the FDA for expanding the use of ...
News
Accelerated approval, real-world evidence pilot from ICER, Aetion picks HAE as first therapeutic area
ICER signals how it will pick other therapies for pilot in an interview with Pink Sheet. ...
News
Coronavirus infection leads to immunity that’s comparable to a COVID-19 vaccine
One of the enduring questions of the COVID-19 pandemic is how much immunity people are ...
News
COVID-19 antibodies may protect against reinfection later, study suggests
A study published in the journal JAMA Internal Medicine found that people who tested ...
News
Aetion: Fierce 15 Awards 2021
Amidst unprecedented challenges, adaptability emerged as a key determinant of success for ...
News
SARS-CoV-2 antibodies can protect from reinfection, NCI study suggests
As COVID-19 vaccines start to roll out in the US, research led by the National Cancer ...
News
Her Story podcast: Fitting the pieces together with Carolyn Magill
This podcast episode features an interview with Carolyn Magill, the CEO of Aetion, a ...
News
‘Unpredictable pathogen’: New coronavirus study highlights severity of illness
While COVID-19 is commonly associated with symptoms like a loss of smell or taste, a new ...
News
Health analytics startup expands partnership with global pharma firm
As president and chief operating officer of Mount Sinai Hospital, Dr. David Reich ...
News
Data-driven approach to COVID-19 requires rigor, transparency
Aetion CEO Carolyn Magill spoke with S&P Global Market Intelligence about the ...
News
MedCity Pivot: Real-world evidence with Carolyn Magill
Arundhati Parmar interviewed Carolyn Magill, CEO of Aetion. They discussed the growing ...
News
Ask the Experts: applications of real-world data during—and beyond—COVID-19
In this ‘Ask the Experts’ feature, explore some of the potential applications of ...
News
Aetion adds another $19M to its Series B to make sense of drug development and treatment data
AlleyWatch caught up with CEO Carolyn Magill to learn more about how the company powers ...
News
Aetion pushes Series B to $82M as pandemic puts real-world evidence under the spotlight
Former FDA chief Scott Gottlieb’s favorite real-world evidence platform is getting a new ...
News
Aetion, Cegedim Health Data partner on European RWE effort
Outsourcing Pharma writes in July 2020, Aetion and Cegedim Health Data announce plans to ...